|
China Feihe Limited is a dairy company focused on the research, development, production, and sale of infant formula and full life-cycle nutrition products. The company operates in the infant formula, children's nutrition, and adult nutrition segments, with its core business centered on infant formula. Key brands include Star Fei Fan (Xing Fei Fan) and Feihe. The company maintains a vertically integrated supply chain, managing raw milk production and processing through its own farms and smart factories located in Harbin, Qiqihar, Kedong, Gannan, and Hengqin. It serves the Chinese market and has expanded into international markets through its facility in Canada. Notable partnerships include collaborations with Harvard Medical School's BIDMC and Peking University Health Science Center for brain development research, as well as roles as an official partner for the 9th Asian Winter Games and the Chang'e-5 lunar exploration program. The company's origins trace back to 1962 with the establishment of its predecessor, the Zhaoguang Farm Dairy Products Factory. Summarised from the company's own disclosures, fiscal year ended Apr 2026 |
Industry Packaged Foods | Homepage feihe.com |
| Sector Consumer Defensive | IR page chinafeiheir.com/InvestorHome_cn | |
|
Tags
infant formula, dairy products, raw milk, nutritional products, milk protein, brain development, hmos, lactoferrin, smart manufacturing, Star Fei Fan, Feihe, Feihe HLJ, Feihe (Gannan) Dairy Products Co. Ltd., Vitamin World USA, YST, Zhaoguang Farm, Zhaoguang Dairy, Feihe-Harvard Medical School BIDMC Nutrition Laboratory
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | HK$ 25.49B |
| Market cap (USD) | $ 3.248B |
| P/E | 12.02 |
| PEG | — |
| P/BV | 0.85 |
| P/S | 1.18 |
| P/OCF | 4.93 |
| P/FCF | — |
| Dividend yield | 17.3% |
| Turnover / mcap | 0.26% |
| Returns | |
|---|---|
| ROE | 7.2% |
| ROI | 7.3% |
| ROIC | 7.3% |
| Profit margin | 10.7% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | -26.8% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | 1.5% |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 5.9% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpAnnouncements and reports published on HKEXnews, newest first, monthly and next-day returns, proxy forms and board-meeting notices included. The link opens the announcement on HKEXnews.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding China Feihe Limited
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVEE | 0.17% | 615,000 | $ 219.728K | Nov 16, 2026 |
| AVES | 0.07% | 2,623,000 | $ 937.15K | Nov 16, 2026 |
| AVEM | 0.04% | 33,119,000 | $ 11.833M | Nov 16, 2026 |
| DFEV | 0.03% | 1,695,000 | $ 596.355K | Nov 12, 2026 |
| MEMA | 0.01% | 4,000 | $ 1,431.25 | Aug 31, 2026 |
| DFAX | 0.00% | 441,000 | $ 155.158K | Nov 12, 2026 |
| DFEM | 0.00% | 259,000 | $ 91.125K | Nov 12, 2026 |